2024 Proteins C and S Testing Market: USA, Europe, Japan--Competitive Strategies, Country Forecasts, Innovative Technologies and Instrumentation

August 2024 | | ID: 2951DE8F7F60EN
Venture Planning Group

Abstracts

The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next five years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Proteins C and S testing specifically, will become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the Proteins C and S testing closer to the patient, creating additional opportunities and challenges for suppliers.This report presents a detailed analysis of the Proteins C and S testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5-year test volume forecasts by country and market segment.The report examines market applications of chromogenic substrates, monoclonal antibodies, immunoassays, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.Contains 194 pages and 15 tables

Contents

I. Introduction
II. Market and Technology Overview
A. Introduction
B. Clinical Significance and
Current Laboratory Procedures
C. Coagulation Instrumentation Review: Leading analyzers marketed by Abbott, Beckman
Coulter/Danaher, Becton Dickinson, Diagnostica Stago, Grifols, Helena Laboratories,
IL/Werfen, Roche, Sekisui Diagnostics, Siemens Healthineers, Sysmex, and Thermo Fisher.
D. Major in Vitro Diagnostic Technologies and Their
Potential Applications
E. Chromogenic Substrates
F. Monoclonal and Polyclonal Antibodies
G. Immunoassays
a. Applications
b. Technological Principle
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- EMIT
- Dot Immunobinding Assays
- Capillary Immunoassays
- Enzyme Amplification
- Electrochemical Immunoassay
d. Fluorescent Immunoassays
- Fluorescence Polarization
- Time-Resolved Pulse Fluorescence
- Fluorescence Lifetime
e. Latex Agglutination
f. Immunoprecipitation
H. Microcomputers
I. Automation

6. Robotics
7. DNA Probes
a. Overview
b. Amplification Methods
8. Artificial Intelligence
9. Dry Chemistry
10. Biosensors
III. France: Test Volume Forecasts by Market Segment
IV. Germany: Test Volume Forecasts by Market Segment
V. Italy: Test Volume Forecasts by Market Segment
VI. Japan: Test Volume Forecasts by Market Segment
VII. Spain: Test Volume Forecasts by Market Segment
VIII. UK: Test Volume Forecasts by Market Segment
IX. USA: Test Volume Forecasts by Market Segment
X. Design Criteria For Decentralized Testing Products
XI. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Market
1. Marketing Approaches
2. Product Complexity